文献速递肺结节与肺癌

TSANZ临床医生实践指南:筛查与偶发肺结节的管理

The TSANZ Practical Guide for Clinicians in the Management of Screen- and Incidentally-Detected Nodules.
PubMed 文献 · Respirology · 2025-05-29

该指南由TSANZ制定,针对筛查和偶发检出的不确定肺结节(IPN),强调以患者为中心的多学科管理。指南按大小和形态对IPN分类,提出恶性风险分层、诊断评估和随访的具体推荐,并倡导肺结节评估团队(LNET)和多学科会议(MDM)以确保指南依从、优化活检、减少不必要检查。

要点

  • 按结节大小和形态分类,进行恶性风险分层并制定随访方案。
  • 肺结节评估团队和多学科会议可提高指南依从性、减少不必要检查。
  • 使用标准化报告模板和验证风险模型(如PanCan模型)辅助管理。

核心结论

  • 整合多学科专业知识和循证方案可改善IPN的及时诊断与管理,减少过度检查和过度诊断,最终提升患者结局和肺癌生存率。

研究设计与样本

  • 本文为TSANZ制定的临床实践指南,针对筛查和偶发检出的不确定肺结节(IPN)的管理。

主要发现

  • 结构化IPN项目在早期肺癌检测、提高早期肺癌检出率和减少治疗延迟方面显示出获益。
  • LNET和结节MDM在确保指南依从、简化诊断路径、减少不必要检查和改善结局中起关键作用。
  • 使用标准化报告模板和验证风险模型(如PanCan恶性风险模型)是有效管理策略。
  • 获取既往影像评估生长并考虑CT技术差异很重要,疑似生长的结节需MDM讨论决定活检。

关键数值与推荐

  • IPN根据大小和形态进行分类,并据此制定恶性风险分层、诊断评估和随访的具体指南。
  • 推荐使用标准化报告模板和验证风险模型(如PanCan恶性风险模型)以及商定的IPN随访方案。
  • 任何考虑为生长的结节均需在结节MDM上讨论,并酌情决定进行组织活检。

临床怎么用

  • 临床医生应按照指南对IPN进行大小和形态分类,并应用风险分层和随访方案。
  • 建议建立LNET和结节MDM以确保指南依从性并优化诊断路径。
  • 使用标准化报告模板和验证风险模型(如PanCan模型)辅助决策。
  • 获取既往影像对比评估生长,并考虑CT技术差异。
  • 疑似生长的结节应提交MDM讨论,以选择最安全有效的活检技术。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The increasing adoption of lung cancer screening programs and advancements in imaging technologies has significantly increased the detection of pulmonary nodules, both incidentally and through screening. This document provides a comprehensive guide for clinicians to address the complexities of managing indeterminate pulmonary nodules (IPNs), emphasising person-centred and multidisciplinary care. IPNs are categorised based on size and morphology, with specific guidelines for malignancy risk stratification, diagnostic evaluation, and follow-up. Dedicated lung nodule evaluation teams (LNETs) and nodule multidisciplinary meetings (MDMs) play a critical role in ensuring guideline adherence, streamlining the diagnostic pathway, reducing unnecessary investigations, and improving outcomes. Structured IPN programs have demonstrated benefits in early lung cancer detection, improved detection of early-stage lung cancer, and reduced delays to treatment initiation. Effective management strategies include use of standardised reporting templates, utilising validated risk models such as the PanCan malignancy risk model and agreed protocols for follow up of IPNs. This document highlights the importance of accessing prior imaging to assess for growth and accounting for technical differences between computed tomography (CT) scans. Any nodule considered to be growing requires discussion at a nodule MDM with decision to act for tissue biopsy as appropriate. A nodule MDM will assist in optimising the safest and most efficient biopsy techniques based on nodule characteristics and risk profile. By integrating multidisciplinary expertise and adhering to evidence-based protocols, services can improve the timely diagnosis and management of IPNs, minimise over-investigation, reduce chance of overdiagnosis and ultimately enhance patient outcomes and lung cancer survival.

来源:Respirology,查看原文。版权归原作者所有。

引用

  1. Brims F, McWilliams A, Williamson J, et al. The TSANZ Practical Guide for Clinicians in the Management of Screen- and Incidentally-Detected Nodules. Respirology. 2025. PMID: 40438947. doi:10.1111/resp.70065

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。